A critical advance in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This essential malignant protector protein is frequently disabled in several forms of tumors, resulting https://bookmarkjourney.com/story21948519/vhh-fragments-reactivate-the-p53-protein-the-promising-hope-for-malignant-treatment